OncoImmunology
Volume 9, 2020 - Issue 1
Research Article
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination
Tanja Lövgrena Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;b Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
https://orcid.org/0000-0003-2170-0682View further author information
https://orcid.org/0000-0003-2170-0682View further author information, , Stina Wickströma Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Swedenhttps://orcid.org/0000-0003-0349-4918View further author information
https://orcid.org/0000-0003-0349-4918View further author information, , , , , , , Andreas Lundqvista Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Swedenhttps://orcid.org/0000-0002-9709-2970View further author information
https://orcid.org/0000-0002-9709-2970View further author information, , , , , Giuseppe Masuccia Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Swedenhttps://orcid.org/0000-0002-9583-2306View further author information
https://orcid.org/0000-0002-9583-2306View further author information, , Isabel Poschkea Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;i DKTK Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germanyhttps://orcid.org/0000-0002-4387-5566View further author information
https://orcid.org/0000-0002-4387-5566View further author information, , Jonas Mattssona Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;j Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network, University of Toronto, Toronto, Canadahttps://orcid.org/0000-0002-2163-6644View further author information
https://orcid.org/0000-0002-2163-6644View further author information & Rolf Kiesslinga Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
https://orcid.org/0000-0003-0663-5763View further author information
https://orcid.org/0000-0003-0663-5763View further author information show all